|
Sign In to gain access to subscriptions and/or personal tools.
|
A Prospective Multicenter Study to Evaluate the Feasibility and Safety of Aggressive Antihypertensive Treatment in Patients With Acute Intracerebral Hemorrhage
Adnan I. Qureshi, MD
Institute of New Jersey, 90 Bergen Street, DOC-8100, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103-2425aiqureshi{at}hotmail.com
Yousef M. Mohammad, MD
Cleveland OH, and University of Mississippi; Jackson, MS
Abutaher M. Yahia, MD
Zeenat Qureshi Stroke Reseach Center, the Department of Neurology and Neurosciences
Jose I. Suarez, MD
The University of Medicine and Dentistry of New Jersey, Newark, NJ; Departments of Neurology at University Hospitals of Cleveland
Amir M. Siddiqui, MD
Zeenat Qureshi Stroke Reseach Center, the Department of Neurology and Neurosciences
Jawad F. Kirmani, MD
Zeenat Qureshi Stroke Reseach Center, the Department of Neurology and Neurosciences
M. Fareed K. Suri, MD
The University of Medicine and Dentistry of New Jersey, Newark, NJ; Departments of Neurology at University Hospitals of Cleveland
James Kolb, MD
Cleveland OH, and University of Mississippi; Jackson, MS
Osama O. Zaidat, MD
The University of Medicine and Dentistry of New Jersey, Newark, NJ; Departments of Neurology at University Hospitals of Cleveland
The authors performed a multicenter prospective observational study to evaluate the feasibility and safety of intravenous antihypertensive protocol for acute hypertension in patients with intracerebral hemorrhage (ICH). Twentyseven patients with ICH and acute hypertension (mean age 61.37 ± 14.27; 10 were men) were treated to maintain the systolic blood pressure (BP) below 160 mm Hg and diastolic BP below 90 mm Hg within 24 hours of symptom onset. Neurological deterioration (defined as a decrease in initial Glasgow Coma Scale score= 2) was observed in 2 (7.4%) of 27 patients during treatment. Among patients who underwent follow-up computed tomography, hematoma expansion (more than 33% increase in hematoma size at 24 hours) was observed in 2 (9.1%) of 22 patients. Patients treated within 6 hours of symptom onset were more likely to be functionally independent (modified Rankin scale= 2) at 1 month compared with patients who were treated between 6 and 24 hours (8 of 18 versus 0 of 9,P= .03). Aggressive pharmacological treatment of acute hypertension in patients with ICH can be initiated early with a low rate of neurological deterioration and hematoma expansion.
Key Words: intracerebral hemorrhage hypertension labetalol computed tomographic scan neurological deterioration
Journal of Intensive Care Medicine, Vol. 20, No. 1,
34-42 (2005)
DOI: 10.1177/0885066604271619

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y.-C. Chuang, Y.-M. Chen, S.-K. Peng, and S.-Y. Peng
Risk stratification for predicting 30-day mortality of intracerebral hemorrhage
Int. J. Qual. Health Care,
December 1, 2009;
21(6):
441 - 447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rhoney and W. F. Peacock
Intravenous therapy for hypertensive emergencies, part 2
Am. J. Health Syst. Pharm.,
August 15, 2009;
66(16):
1448 - 1457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Qureshi
Acute Hypertensive Response in Patients With Stroke: Pathophysiology and Management
Circulation,
July 8, 2008;
118(2):
176 - 187.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al.
REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Circulation,
October 16, 2007;
116(16):
e391 - e413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al.
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Stroke,
June 1, 2007;
38(6):
2001 - 2023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Jauch, C. J. Lindsell, O. Adeoye, J. Khoury, W. Barsan, J. Broderick, A. Pancioli, and T. Brott
Lack of Evidence for an Association Between Hemodynamic Variables and Hematoma Growth in Spontaneous Intracerebral Hemorrhage
Stroke,
August 1, 2006;
37(8):
2061 - 2065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Godoy, G. Pinero, and M. Di Napoli
Predicting Mortality in Spontaneous Intracerebral Hemorrhage: Can Modification to Original Score Improve the Prediction?
Stroke,
April 1, 2006;
37(4):
1038 - 1044.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|